TILS.L Regulatory News (TILS)

10 Oct 2005 10:51

ReGen Therapeutics PLC10 October 2005 REGEN THERAPEUTICS PLC Results of Extraordinary General Meeting 10 October 2005 ReGen Therapeutics Plc (the "Company") announces that at the ExtraordinaryGeneral Meeting of the Company held earlier today, Shareholders passed all ofthe resolutions including those relating to the Placing and the Committed ShareFinance Facility, as announced by the Company on 15 September 2005 and asdetailed in the circular sent to shareholders dated 16 September 2005. As a result, it is expected that 66,600,000 new ordinary shares will be allottedto new and existing shareholders at 1p per share (the "Second Placing Shares")raising the Company £666,000, before expenses. Accordingly, the total amountexpected to be raised, pursuant to the Placing is £1,566,000, before expenses.Application has been made for the Second Placing Shares, which will rank paripassu with existing ordinary shares in issue, to be admitted to trading to theAIM market of the London Stock Exchange, and it is expected that admission willbecome effective at 8.00 a.m. on 13 October 2005. For further information please contact: Andrew MarshallGreycoat CommunicationsTel: 020 7960 6007 This information is provided by RNS The company news service from the London Stock Exchange